BVS News and Press, Bioventus Inc. From 01/24/23

Boston, Massachusetts--(Newsfile Corp. - January 24, 2023) - Block & Leviton announces that a class action lawsuit has been filed against Bioventus, Inc. (NASDAQ: BVS) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to l...

NEW YORK, NY / ACCESSWIRE / January 20, 2023 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ:BVS) and reminds investors of the March 13, 2023 deadline to seek the role of lead plai...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Bioventus To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 18, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...

DURHAM, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 5...

NEW YORK, NY / ACCESSWIRE / December 2, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ:BVS). If you suffered losses exceeding $50,000 investing in Bioventus stock or option...

DURHAM, N.C., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today amended its previously announced financial results for the three and nine months ended October 1, 2022. Due to the...

Boston, Massachusetts--(Newsfile Corp. - November 18, 2022) - Block & Leviton is investigating Bioventus, Inc. (NASDAQ: BVS) for potential securities law violations. Investors who have lost money in their Bioventus, Inc. investment should contact the firm  to learn more about how the...

DURHAM, N.C., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the Company has filed a Form 12b-25, Notification of Late Filing for its Quarte...

Bioventus Inc. (BVS) Q3 2022 Earnings Conference Call November 08, 2022, 08:30 AM ET Company Participants Dave Crawford - VP of IR Ken Reali - CEO Mark Singleton - SVP and CFO Conference Call Participants Chase Knickerbocker - Craig-Hallum Capital Gro...

Shares of Bioventus (NASDAQ: BVS) fell 14% on Wednesday. The medical device company's stock closed on Tuesday at $3 a share, then opened on Wednesday at $2.90. The stock fell to as low as $2.25 before bouncing back a bit to $2.58 at the close. The stock is down more than 82% this ye...